Internal Medicine, Hematology & Oncology · Santa Isabel, PR
NPI
1124214903
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
Carretera 153 Km 7.3 Plaza Santa Isabel Suite 15
Santa Isabel, PR, 00797
Phone (787) 845-0805
Groups this clinician bills Medicare through
Medicare paid, 2024
$123K
2,238 services
Medicare patients, 2024
23
Average age 79
Drug cost, 2024
$5.3M
1,975 prescriptions
Company payments, 2025
$2,899
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nelson A Matos-Fernandez was code 99213 (office e&m - established), 44 times for 20 patients. In total Nelson A Matos-Fernandez billed 2,238 services in 11 codes, and Medicare paid $123K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-01-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 44 | 20 | $62.33 | $2,743 |
By year: 2022 $264K for 19,073 services; 2023 $159K for 8,882 services; 2024 $123K for 2,238 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nelson A Matos-Fernandez prescribed most often to Medicare patients was Anastrozole, with 669 prescriptions and refills. In total Nelson A Matos-Fernandez wrote 1,975 Medicare prescriptions that cost $5.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 669 | 819 | 110 | $11K |
| Bicalutamide Generic | 154 | 160 | 23 | $4,527 |
| Letrozole Generic | 68 | 84 | 13 | $896 |
| Ondansetron Odt Ondansetron | 67 | 67 | 34 | $1,300 |
| Prednisone Generic | 61 | 61 | 23 | $454 |
| Sprycel Dasatinib | 58 | 58 | Under 11 | $917K |
| Dexamethasone Generic | 57 | 57 | 24 | $1,272 |
| Famotidine Generic | 55 | 61 | 24 | $413 |
| Imatinib Mesylate Generic | 50 | 50 | Under 11 | $63K |
| Megestrol Acetate Generic | 41 | 41 | 15 | $2,527 |
| Avastin Bevacizumab | 32 | 32 | Under 11 | $137K |
| Hydroxyurea Generic | 30 | 30 | Under 11 | $679 |
| Gabapentin Generic | 29 | 33 | Under 11 | $236 |
| Verzenio Abemaciclib | 28 | 28 | Under 11 | $432K |
| Retacrit Epoetin Alfa-Epbx | 27 | 27 | 18 | $25K |
Brand drugs: 473 claims; generic drugs: 1,502 claims; opioid claims: 45.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nelson A Matos-Fernandez $2,899 ($2,899 in general payments such as food, travel and fees) from 22 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $450.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 20 | $450 |
| Janssen Pharmaceuticals, Inc JNJ | 19 | $443 |
| Merck Sharp & Dohme LLC MRK | 15 | $350 |
| E.R. Squibb & Sons, L.L.C. BMY | 14 | $323 |
| Genentech USA, Inc. ROG.SW | 9 | $201 |
| Pbg Puerto Rico LLC | 9 | $194 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $158 |
| Abbvie Inc. ABBV | 7 | $138 |
| Puma Biotechnology, Inc. PBYI | 4 | $99.98 |
| Genzyme Corporation SNY | 3 | $66.04 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.